Cargando…

Factors related to survival time in dogs with pulmonary hypertension secondary to degenerative mitral valve disease stage C

Pulmonary hypertension (PH) is a common complication in dogs with degenerative mitral valve disease (DMVD). The aim of this study was to determine the survival time and to determine factors related to the survival time of dogs with PH secondary to DMVD stage C. A retrospective study was conducted in...

Descripción completa

Detalles Bibliográficos
Autores principales: Udomkiattikul, Jutamas, Kirdratanasak, Noppasorn, Siritianwanitchakul, Panatsada, Worapunyaanun, Wasaporn, Surachetpong, Sirilak Disatian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068001/
https://www.ncbi.nlm.nih.gov/pubmed/35573138
http://dx.doi.org/10.1080/23144599.2022.2067630
_version_ 1784700135357284352
author Udomkiattikul, Jutamas
Kirdratanasak, Noppasorn
Siritianwanitchakul, Panatsada
Worapunyaanun, Wasaporn
Surachetpong, Sirilak Disatian
author_facet Udomkiattikul, Jutamas
Kirdratanasak, Noppasorn
Siritianwanitchakul, Panatsada
Worapunyaanun, Wasaporn
Surachetpong, Sirilak Disatian
author_sort Udomkiattikul, Jutamas
collection PubMed
description Pulmonary hypertension (PH) is a common complication in dogs with degenerative mitral valve disease (DMVD). The aim of this study was to determine the survival time and to determine factors related to the survival time of dogs with PH secondary to DMVD stage C. A retrospective study was conducted in 37 dogs with PH secondary to DMVD stage C to analyse the median survival time and associated factors such as age, sex, breed, body weight, the presence of syncope, heart rate, systolic blood pressure, manifestation of congestive heart failure (CHF), vertebral heart score (VHS), the presence of left or right heart enlargement, probability of PH and medication. Data were analysed using the Log-Rank test and plotted with the Kaplan-Meier curve. The results showed that the median survival time of dogs with PH secondary to DMVD stage C was 368 days, and factors that shortened the median survival time of dogs with PH secondary to DMVD stage C were mixed breeds, VHS > 11.5, the presence of right heart enlargement, ascites and high probability of PH. Factors associated with an increased hazard of death were mixed breed dogs, dogs with right heart enlargement and ascites. These findings may be useful for the prognosis and management of dogs with PH secondary to DMVD stage C.
format Online
Article
Text
id pubmed-9068001
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-90680012022-05-12 Factors related to survival time in dogs with pulmonary hypertension secondary to degenerative mitral valve disease stage C Udomkiattikul, Jutamas Kirdratanasak, Noppasorn Siritianwanitchakul, Panatsada Worapunyaanun, Wasaporn Surachetpong, Sirilak Disatian Int J Vet Sci Med Research Article Pulmonary hypertension (PH) is a common complication in dogs with degenerative mitral valve disease (DMVD). The aim of this study was to determine the survival time and to determine factors related to the survival time of dogs with PH secondary to DMVD stage C. A retrospective study was conducted in 37 dogs with PH secondary to DMVD stage C to analyse the median survival time and associated factors such as age, sex, breed, body weight, the presence of syncope, heart rate, systolic blood pressure, manifestation of congestive heart failure (CHF), vertebral heart score (VHS), the presence of left or right heart enlargement, probability of PH and medication. Data were analysed using the Log-Rank test and plotted with the Kaplan-Meier curve. The results showed that the median survival time of dogs with PH secondary to DMVD stage C was 368 days, and factors that shortened the median survival time of dogs with PH secondary to DMVD stage C were mixed breeds, VHS > 11.5, the presence of right heart enlargement, ascites and high probability of PH. Factors associated with an increased hazard of death were mixed breed dogs, dogs with right heart enlargement and ascites. These findings may be useful for the prognosis and management of dogs with PH secondary to DMVD stage C. Taylor & Francis 2022-04-29 /pmc/articles/PMC9068001/ /pubmed/35573138 http://dx.doi.org/10.1080/23144599.2022.2067630 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Udomkiattikul, Jutamas
Kirdratanasak, Noppasorn
Siritianwanitchakul, Panatsada
Worapunyaanun, Wasaporn
Surachetpong, Sirilak Disatian
Factors related to survival time in dogs with pulmonary hypertension secondary to degenerative mitral valve disease stage C
title Factors related to survival time in dogs with pulmonary hypertension secondary to degenerative mitral valve disease stage C
title_full Factors related to survival time in dogs with pulmonary hypertension secondary to degenerative mitral valve disease stage C
title_fullStr Factors related to survival time in dogs with pulmonary hypertension secondary to degenerative mitral valve disease stage C
title_full_unstemmed Factors related to survival time in dogs with pulmonary hypertension secondary to degenerative mitral valve disease stage C
title_short Factors related to survival time in dogs with pulmonary hypertension secondary to degenerative mitral valve disease stage C
title_sort factors related to survival time in dogs with pulmonary hypertension secondary to degenerative mitral valve disease stage c
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068001/
https://www.ncbi.nlm.nih.gov/pubmed/35573138
http://dx.doi.org/10.1080/23144599.2022.2067630
work_keys_str_mv AT udomkiattikuljutamas factorsrelatedtosurvivaltimeindogswithpulmonaryhypertensionsecondarytodegenerativemitralvalvediseasestagec
AT kirdratanasaknoppasorn factorsrelatedtosurvivaltimeindogswithpulmonaryhypertensionsecondarytodegenerativemitralvalvediseasestagec
AT siritianwanitchakulpanatsada factorsrelatedtosurvivaltimeindogswithpulmonaryhypertensionsecondarytodegenerativemitralvalvediseasestagec
AT worapunyaanunwasaporn factorsrelatedtosurvivaltimeindogswithpulmonaryhypertensionsecondarytodegenerativemitralvalvediseasestagec
AT surachetpongsirilakdisatian factorsrelatedtosurvivaltimeindogswithpulmonaryhypertensionsecondarytodegenerativemitralvalvediseasestagec